top of page
Developing 21st Century Medicines
PARTNERSHIPS
Transformative innovation begins with great partnerships. At SMDG, we bring together decades of expertise in disease biology, biomarker discovery, drug delivery, data science and nanomedicine to develop the next generation of precision therapeutics. Through strategic collaborations with academic institutions, biotechnology and pharmaceutical companies, clinicians, and patient organizations, we combine our proprietary peptide-based NanoLigand™ platforms with deep biological insights to accelerate the development of first-in-class disease-modifying therapies for patients with significant unmet medical needs.
We believe in the power of partnerships and working with those who share our vision and commitment to patients. We welcome collaborations spanning discovery, platform technologies, biomarker research, therapeutic development, licensing, and strategic partnerships.
We have established an international network of several collaborations across academia, industry and patient advocacy groups.
bottom of page